Qube Research & Technologies LTD Biovie Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding BIVI
# of Institutions
57Shares Held
7MCall Options Held
51.7KPut Options Held
353K-
Altium Capital Management LP New York, NY3.01MShares$1.21 Million0.9% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ689KShares$275,65412.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA645KShares$257,8300.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE600KShares$239,9582.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny347KShares$138,9600.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $12.1M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...